Showing results (1641-1650 of 1,729) with videos related to
Sort By:
Pageof 173
The New England Journal of Medicine|October 26, 2007
Cisplatin and fluorouracil alone or with docetaxel in head and neck cancerMarshall R Posner, Diane M Hershock, Cesar R Blajman, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 21, 2023
Updated progression-free survival and final overall survival with maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trialDomenica Lorusso, Marie-Ange Mouret-Reynier, Philipp Harter, et al.Journal of the National Cancer Institute|April 25, 2026
Health-related quality of life in patients with newly diagnosed advanced ovarian cancer receiving maintenance olaparib plus bevacizumab (PAOLA-1/ENGOT-ov25)Florence Joly, Amélie Anota, Sylvie Chabaud, et al.The Lancet. Oncology|April 20, 2020
Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trialJacobus Pfisterer, Catherine M Shannon, Klaus Baumann, et al.Cell Reports. Medicine|December 20, 2023
GIInger predicts homologous recombination deficiency and patient response to PARPi treatment from shallow genomic profilesChristian Pozzorini, Gregoire Andre, Tommaso Coletta, et al.Journal of Medical Genetics|April 14, 2019
Deleterious somatic variants in 473 consecutive individuals with ovarian cancer: results of the observational AGO-TR1 study (NCT02222883)Jan Hauke, Eric Hahnen, Stephanie Schneider, et al.Cancers|July 14, 2023
Development of the NOGGO GIS v1 Assay, a Comprehensive Hybrid-Capture-Based NGS Assay for Therapeutic Stratification of Homologous Repair Deficiency Driven Tumors and Clinical ValidationEva-Maria Willing, Claudia Vollbrecht, Christine Vössing, et al.Neuro-Oncology|May 6, 2023
Intracranial injection of natural killer cells engineered with a HER2-targeted chimeric antigen receptor in patients with recurrent glioblastomaMichael C Burger, Marie-Therese Forster, Annette Romanski, et al.Human Mutation|October 23, 2022
SPiP: Splicing Prediction Pipeline, a machine learning tool for massive detection of exonic and intronic variant effects on mRNA splicingRaphaël Leman, Béatrice Parfait, Dominique Vidaud, et al.Plos One|October 21, 2017
Prevalence of deleterious germline variants in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1)Philipp Harter, Jan Hauke, Florian Heitz, et al.Pageof 173